Skip to main content
ACG 2023 Annual Meeting Main banner
Back

Oral Paper Presentation

Annual Scientific Meeting
Paper/Abstract Presentations

Plenary Session 4B - IBD / Obesity / Stomach / Pediatrics

Wednesday, October 25, 2023
8:30 AM – 10:15 AM PT
Location: Ballroom B

Livestream

Presentations:

  • 8:30 AM – 8:40 AM PT
    Outcomes of Anti-Obesity Glucagon-Like Peptide 1 Agonists vs Revisional Endoscopic Sleeve Gastroplasty for Weight Regain After Laparoscopic Sleeve Gastrectomy: A Case-Control Real World Experience

    Presenting Author: Firas Bahdi, MD (he/him/his) – David Geffen School of Medicine at University of California Los Angeles

  • 8:40 AM – 8:50 AM PT
    Metoclopramide Use in the Setting of Upper Gastrointestinal Bleed-An Updated Meta-Analysis

    Presenting Author: Diego A. Reymunde Duran, MD – University of Texas Health Science Center at Houston

  • 8:50 AM – 9:00 AM PT
    Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients

    Presenting Author: Richard McCallum, MD (he/him/his) – TTUHSC

  • 9:00 AM – 9:10 AM PT
    Non-Invasive Vagal Nerve Stimulation Reduces Nausea Rescue Medication in Patients With Gastroparesis and Related Disorders, With Additional Benefits on Multiple Other Associated Symptoms

    Presenting Author: Pankaj Pasricha, MD, MBBS – Mayo Clinic Arizona

  • 9:10 AM – 9:20 AM PT
    Efficacy of Guselkumab in Patients With Moderately to Severely Active Crohn’s Disease Not in Clinical Response at Week 12: Results From the GALAXI 1 Study

    Presenting Author: Anita Afzali, MD, MPH, MHCM, FACG – University of Cincinnati

  • 9:20 AM – 9:30 AM PT
    Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study

    Presenting Author: Remo Panaccione, MD – University of Calgary

  • 9:30 AM – 9:40 AM PT
    Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Complex Crohn’s Disease: Results from the EVOLVE Expansion Study

    Presenting Author: Marc Ferrante, MD – University Hospitals Leuven

  • 9:40 AM – 9:50 AM PT
    Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis at 8-16 Weeks: A Multicenter Retrospective Cohort Study

    Presenting Author: Rahul Dalal, MD, MPH (he/him/his) – Brigham and Women's Hospital, Harvard Medical School

  • 9:50 AM – 10:00 AM PT
    Dupilumab Improves Histologic and Endoscopic Aspects of Eosinophilic Esophagitis (EoE), as Well as Rate of Weight Gain, in Children Aged 1 to <12 years: 52-week Results From the Phase 3 EoE KIDS Trial (Late-Breaking Abstract)

    Late Breaking Abstract Presenter: Mirna Chehade, MD, MPH